Cai Yu, Peng Shijing, Duan Bingfen, Shao Yinan, Li Xiaonan, Zou Hua, Fan Huimin, You Zhipeng
Jiangxi Province Division of National Clinical Research Center for Ocular Diseases, Jiangxi Clinical Research Center for Ophthalmic Disease, Jiangxi Provincial Key Laboratory for Vitreoretinal Diseases, Jiangxi Research Institute of Ophthalmology and Visual Science, The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University, Jiangxi, China.
Cell Biol Int. 2025 Jul;49(7):852-864. doi: 10.1002/cbin.70027. Epub 2025 May 7.
Diabetic retinopathy (DR) is a retinal vasculopathy stemming from diabetes mellitus, characterized by microvascular changes in the retina that can lead to visual impairment or even blindness. Ferroptosis, a form of regulated cell death driven by iron accumulation and lipid peroxidation, has been implicated in the progression of DR. Isoquercetin (IQC), a flavonoid compound, has been shown to inhibit cellular ferroptosis and apoptosis, yet its specific role and underlying mechanisms in DR remain to be elucidated. The present study aimed to investigate the effects of IQC on DR and to delineate its protective mechanisms, particularly focusing on whether these effects are mediated through p53. We employed streptozotocin-induced diabetic C57BL/J mouse models and high glucose (HG)-induced human retinal capillary endothelial cells (HRCECs) models for both in vivo and in vitro experiments. Pathological damage was assessed using hematoxylin and eosin staining, while cell apoptosis rates was detected by TUNEL staining and FITC/PI flow cytometry. Mitochondrial damage was evaluated using transmission electron microscopy. Additionally, we measured levels of reactive oxygen species (ROS) and glutathione (GSH) to assess lipid peroxidation and quantified ferrous ions (Fe). Protein expression was detected by immunofluorescence and western blot analysis, and mRNA levels were determined by real-time quantitative PCR. Our findings revealed that IQC mitigated retinal damage in diabetic mice, and in vitro studies further demonstrated that this effect was mediated by the inhibition of p53. In HG-induced HRCECs, we observed decreased cell viability, lipid peroxidation, and ferroptosis. IQC alleviated HG-induced ferroptosis in HRCECs by modulating the p53 pathway, which exhibited varying responses following p53 inhibition or activation. In summary, IQC downregulated the p53 signaling pathway, thereby reducing ferroptosis and apoptosis, and effectively ameliorated the damage associated with DR. These discoveries offer novel insights into the protective mechanisms of IQC in DR.
糖尿病性视网膜病变(DR)是一种源于糖尿病的视网膜血管病变,其特征是视网膜微血管变化,可导致视力损害甚至失明。铁死亡是一种由铁积累和脂质过氧化驱动的程序性细胞死亡形式,与DR的进展有关。异槲皮素(IQC)是一种黄酮类化合物,已被证明可抑制细胞铁死亡和凋亡,但其在DR中的具体作用和潜在机制仍有待阐明。本研究旨在探讨IQC对DR的影响并阐明其保护机制,特别关注这些影响是否通过p53介导。我们使用链脲佐菌素诱导的糖尿病C57BL/J小鼠模型和高糖(HG)诱导的人视网膜毛细血管内皮细胞(HRCEC)模型进行体内和体外实验。使用苏木精和伊红染色评估病理损伤,通过TUNEL染色和FITC/PI流式细胞术检测细胞凋亡率。使用透射电子显微镜评估线粒体损伤。此外,我们测量了活性氧(ROS)和谷胱甘肽(GSH)水平以评估脂质过氧化,并对亚铁离子(Fe)进行定量。通过免疫荧光和蛋白质印迹分析检测蛋白质表达,通过实时定量PCR测定mRNA水平。我们的研究结果表明,IQC减轻了糖尿病小鼠的视网膜损伤,体外研究进一步证明这种作用是通过抑制p53介导的。在HG诱导的HRCEC中,我们观察到细胞活力、脂质过氧化和铁死亡降低。IQC通过调节p53途径减轻了HG诱导的HRCEC铁死亡,p53抑制或激活后表现出不同的反应。总之,IQC下调p53信号通路,从而减少铁死亡和凋亡,并有效改善与DR相关的损伤。这些发现为IQC在DR中的保护机制提供了新的见解。